COVID boosters reduced cancer patients’ hospitalizations and ICU stays by 29%, researchers report in JAMA Oncology. Overall, ...

A recent study revealed that cancer patients are at a significantly higher risk of contracting a severe COVID infection, but ...

By pairing an mRNA-style vaccine with traditional cancer immunotherapy drugs known as immune checkpoint inhibitors, they were ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

As the latest wave of COVID-19 shows no signs of abating, University of South Australia experts say it's not just booster ...

As the latest wave of COVID-19 shows no signs of abating, University of South Australia experts say it's not just booster ...

A Fred Hutch Cancer Center outpatient complex serving more than 60,000 adult patients per year will be renamed the Sloan Clinic in recognition of Stuart and Molly Sloan, who have increased their total ...

In adults 18 years of age and older, Comirnaty Omicron XBB.1.5, Comirnaty JN.1 and Comirnaty KP.2 may be administered concomitantly with a pneumococcal conjugated vaccine (PCV). an unadjuvanted ...

Research exploring novel therapies to fight against bladder cancer and a world-first asthma study are among 18 Western projects drawing more than $15 ...

An experimental mRNA vaccine that supercharges existing cancer treatments could be laying the groundwork for a “universal” cancer vaccine, according to the team behind the breakthrough. Scientists at ...

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...